Streetbeat News

Products Services

VERU

Veru Inc. announced an investor call on January 4, 2024, to discuss recent financing and its strategy to prioritize the development of enobosarm, a treatment for obesity that prevents muscle loss and augments fat loss in combination with GLP-1 drugs. The company plans a Phase 2b trial for enobosarm and expects first clinical data in Q4 2024. The recent financing is expected to support the company beyond the clinical milestones of this trial.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 1:42 pm

IKT

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) issued a shareholder letter updating on its development programs. The company reported progress in its neurodegenerative and cancer therapeutics programs, with a 68% stock price increase since October. The 201 trial for risvodetinib in Parkinson's disease is enrolling patients, expecting results in H2 2024. The FDA granted Orphan Drug Designation for risvodetinib for Multiple System Atrophy. IkT-001Pro, a prodrug of imatinib, completed bioequivalence studies, and a pre-NDA meeting with the FDA is planned for early 2024. The company also developed a new tablet formulation for risvodetinib and is exploring non-oncology indications for IkT-001Pro.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 1:41 pm

RNXT

RenovoRX has announced that a clinical data abstract supporting its lead oncology product, RenovoGem™, and its novel therapy platform, TAMP™, for treating locally advanced pancreatic cancer, has been accepted for the 2024 Society of Interventional Radiology Annual Scientific Meeting.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 1:41 pm

XPON

Expion360 has introduced two new Lithium Iron Phosphate battery storage solutions designed for residential and small business customers. These products aim to enable users to create their own stable micro-energy grid, providing a buffer against power fluctuations and outages.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 1:39 pm

GIB

CGI has been awarded a contract to upgrade Dallas' business management systems, continuing their long-term partnership with the city. The upgrade will include the implementation of CGI Advantage Insight, automated testing, a new user interface with advanced automation, and features for grants life cycle management and performance budgeting. The financial terms of the contract were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 1:36 pm

GBTC

Tidal Commodities Trust I has filed with the SEC for a new spot Bitcoin ETF under the series 7RCC Spot Bitcoin and Carbon Credit Futures ETF. The fund aims to reflect the price of Bitcoin and Carbon Credit Futures in an 80:20 ratio and plans to list on the NYSE with the symbol 'BTCK'. Other firms like VanEck, Bitwise, Fidelity, and Valkyrie have also proposed similar ETFs, while Grayscale is lobbying to convert its Bitcoin Trust into an ETF.

Portfolio Pulse from Murtuza Merchant

December 19, 2023 | 1:35 pm

INBS

Intelligent Bio Solutions has been accredited by the National Association of Testing Authorities for its drug screening solution, Intelligent Fingerprinting. This accreditation could enhance the credibility and adoption of their product in the market.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 1:34 pm

ALDX

CGEN

IFBD

Compugen announced it will receive a $10M milestone payment as its drug enters a Phase 3 trial with AstraZeneca for biliary tract cancer, causing CGEN stock to surge 240%. Infobird reported a new business cooperation in software development for IT systems, leading to a 152% increase in IFBD shares. Aldeyra Therapeutics revealed positive Phase 2 trial results for ADX-629 in treating atopic dermatitis, resulting in a 42% rise in ALDX stock.

Portfolio Pulse from ryanfaloona@benzinga.com

December 19, 2023 | 1:33 pm

SIDU

Sidus Space (NASDAQ:SIDU) has been granted a new U.S. patent for an Electromagnetic Interference (EMI) Filter Unit, which is expected to enhance cockpit gauge stability in aircraft systems. The patent, No. 11,839,028 B2, is part of Sidus' growing portfolio, now comprising 10 granted patents and 11 pending applications. The technology aims to improve the reliability and security of cockpit instruments and is protected internationally under the Patent Cooperation Treaty, with further international applications planned for Q1 2024.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 1:32 pm

BA

Boeing Co (NYSE:BA) stock is trading higher after Lufthansa Group placed an order for up to 100 737 MAX jets, including a firm order for 40 737-8 planes and options for up to 60 more. This marks the return of the Boeing 737 family to Lufthansa's fleet and is expected to help the airline meet its sustainability targets with improved fuel efficiency and reduced emissions. Boeing shares were up 0.86% at $262.56 following the announcement.

Portfolio Pulse from Adam Eckert

December 19, 2023 | 1:24 pm